About Enhancer

Enhancer ID: E_01_0704
Species: human
Position : chr8:127397745-127399745
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Oophoroma
Pubmed ID:  29435081
Enhancer experiment: Total RNA extraction,RT?qPCR,Small interfering RNAs (siRNAs) and transfection,Monolayer wound healing assay,Transwell invasion assay,Western blot,TOP?FLASH luciferase assay
Enhancer experiment description: Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer.

About Target gene

Target gene : CCAT2
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer.

About TF

TF name : --
TF experiment: Total RNA extraction,RT?qPCR,Small interfering RNAs (siRNAs) and transfection,Monolayer wound healing assay,Transwell invasion assay,Western blot,TOP?FLASH luciferase assay
TF experiment description: Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer.

About Function

Enhancer function : Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs